Maltais, F.
Naya, I. P.
Vogelmeier, C. F.
Boucot, I. H.
Jones, P. W.
Bjermer, L.
Tombs, L.
Compton, C.
Lipson, D. A.
Kerwin, E. M.
Funding for this research was provided by:
GlaxoSmithKline (study number 201749)
Article History
Received: 24 April 2020
Accepted: 9 July 2020
First Online: 22 October 2020
Ethics approval and consent to participate
: EMAX was conducted according to the principles of the Declaration of Helsinki and each site was required to obtain ethics committee/institutional review board approval. Written informed consent was obtained from each patient prior to study screening.
: Not applicable.
: IHB, PWJ, CC and DAL are employees of GlaxoSmithKline (GSK) and hold stocks and shares in GSK. IPN was an employee of GSK at the time of the study, holds stocks and shares in GSK and is a contingent worker on assignment at AstraZeneca. LT is a contingent worker on assignment at GSK. FM has received research grants for participating in multicentre trials for AstraZeneca, Boehringer Ingelheim, GSK, Sanofi and Novartis, and has received unrestricted research grants and personal fees from Boehringer Ingelheim, Grifols and Novartis. CFV has received grants from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Grifols, Mundipharma, Novartis and the German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), and has received personal fees from AstraZeneca, Boehringer Ingelheim, Berlin Chemie/Menarini, Chiesi, CSL Behring, GSK, Grifols, MedUpdate, Mundipharma, Novartis, Nuvaira and Teva. LB has received honoraria for giving a lecture or attending an advisory board for Airsonett, ALK-Abello, AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Meda, Novartis and Teva. EMK has served on advisory boards, speaker panels or received travel reimbursement from Amphastar, AstraZeneca, Boehringer Ingelheim, GSK, Mylan, Novartis, Pearl, Sunovion, Teva and Theravance, and has received consulting fees from Cipla and GSK. ELLIPTA and DISKUS are owned by/licensed to the GSK group of companies.